TITLE

Discontinuing antiepileptic drugs in patients who are seizure free on monotherapy

AUTHOR(S)
Specchio, L. M.; Tramacere, L.; La Neve, A.; Beghi, E.
PUB. DATE
January 2002
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jan2002, p22
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66345879

 

Related Articles

  • DISCONTINUATION OF AEDs. TATUM IV, WILLIAM O.; KAPLAN, PETER W.; JALLON, PIERRE // Epilepsy A to Z: A Concise Encyclopedia;2009, p97 

    An encyclopedia entry for "discontinuation of antiepileptic drugs (AEDs)" is presented. It states that about 65 percent of patients with epilepsy (PWE) become seizure-free with AEDs. It notes that discontinuation of AEDs with some idiopathic generalized epilepsies (IGEs) have a possibility of...

  • Conducta terapéutica después de cirugía de epilepsia. Ruiz-Sandoval, José Luis; González-Cornejo, Salvador; Léon-Jiménez, Carolina // Revista Mexicana de Neurociencia;ene/feb2007, Vol. 8 Issue 1, p596 

    In nonsurgical epilepsy, antiepileptic drugs (AED) are reduced in an attempt to discontinue the drugs completely in seizure-free patients. However, in post-surgical epilepsy patients there is a not an information guides about whether and when AED can be discontinued, in whom and how to reached....

  • Generalized seizures aggravated by levetiracetam in an adult patient with phenylketonuria. Dericioglu, Nese; Saygi, Serap // Metabolic Brain Disease;Jun2010, Vol. 25 Issue 2, p207 

    Phenylketonuria (PKU) is one of the most common inherited metabolic disorders, which is characterized by excessive accumulation of phenylalanine (Phe) in tissues. Generalized seizures occur in 25% of the patients. Little is known about seizures and their treatment in adult PKU patients, and...

  • Modern treatment strategies for patients with epilepsy: a review. Duncan, J. S. // Journal of the Royal Society of Medicine;Mar1991, Vol. 84 Issue 3, p159 

    Of patients who develop epilepsy 70-80% will become seizure free, the remaining 20% are the most difficult to treat satisfactorily. Eighty per cent of patients are best treated with a single drug. Stepwise treatment plans for the treatment of newly diagnosed patients and for the evaluation of...

  • Current Literature Does Epilepsy Surgery Convert Medical Intractable Temporal Lobe Epilepsy to a Medically Treatable Seizure Disorder? Kanner, Andres M. // Epilepsy Currents;May/Jun2004, Vol. 4 Issue 3, p114 

    Wieser HG, Hane A Epilepsy Res 2003;55:211–223 Retrospectively, we analyzed pre- and postoperative (po) antiepileptic drug (AED) treatment in relation to long-term annual seizure outcome in the Zurich selective amygdalohippocampectomy (AHE) series. In 376 patients [hippocampal sclerosis...

  • Reinvestigation and Reduction of Polytherapy in Children With Chronic Seizures. Chu-Chin Chen; Pao-Chin Chiu; Mei-Tsen Chen // Journal of Child Neurology;Jan2007, Vol. 22 Issue 1, p15 

    From October 2001 to October 2003, the authors reviewed all patients with chronic seizures taking antiepileptic drugs for more than 2 years with follow-up at the pediatric neurological clinic. They identified 31 patients who were using 3 or more drugs. Twenty-nine patients agreed to undergo a...

  • Topiramate: As Monotherapy in Newly Diagnosed Epilepsy. Waug, John; Goa, Karen L. // CNS Drugs;2003, Vol. 17 Issue 13, p985 

    â–´ Topiramate is an antiepileptic drug that has a broad spectrum of antiseizure effects, which appear to be the result of several neurostabilising pharmacological mechanisms. These include blockade of ion channels, potentiation of GABA neuroinhibition and glutamate receptor antagonism at...

  • Epileptic seizure reappearance risk, after antiepileptic drug withdrawal in children with cerebral palsy. Kneževic-Pogancev, Marija; Filipovic, Danka; Ivetic, Vesna; Mikov, Aleksandra; Vukovic, Dusan // HealthMed;2011, Vol. 5 Issue 5, p1281 

    Children with cerebral palsy and epilepsy have essentially the same risk for seizure relapse after antiepileptic drug treatment discontinuation when compared with other epileptic children. Decision to withdraw antiepileptic therapy has to be based on a balanced view of the overall risk of...

  • Efficacy of Topiramate in Adult Patients with Symptomatic Epilepsy: An Open-Label, Long-Term, Retrospective Observation. Yang Lu; Weihua Yu; Xuefeng Wang // CNS Drugs;2009, Vol. 23 Issue 4, p351 

    Background: Topiramate is a newer generation antiepileptic drug with a wide range of antiepileptic efficacy as monotherapy or as adjunctive therapy, and which has shown positive activity in intractable epilepsy and newly diagnosed epilepsy. Topiramate has also been shown to exert good seizure...

  • Retrospective Study of the Use of Levetiracetam in Childhood Seizure Disorders. Koukkari, Mark W. // Journal of Child Neurology;Dec2004, Vol. 19 Issue 12, p944 

    The purpose of this study was to assess the efficacy and safety of levetiracetam in a diverse pediatric epilepsy population. A retrospective chart review of 52 consecutive children age 8 months to 16 years who were treated with levetiracetam was performed. The data include patients with partial...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics